Delivery Order SPE2DB20D9127-SPE2DB25FPQJ2

Award Date 4/25/25
Potential Completion Date 5/16/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,568,384,300 units of the YF-VAX 1 dose vaccine. The contract has a ceiling value of $1,113.42 and an ultimate completion date of June 13, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,670.13, is for the delivery of 4,567,939,520 units of the YF-VAX 1 dose vaccine. The contract has an ultimate completion date of May 1, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,930.78, is for the delivery of 4,568,084,755 units of the YF-VAX 1 dose vaccine. The contract has an ultimate completion date of May 1, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,568,429,654 units of the YF-VAX 1 dose vaccine, with a ceiling value of $3,340.26 and a completion date of June 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,226.84, is for the delivery of 4,568,168,523 units of the YF-VAX 1 dose vaccine vials. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,772.79 firm fixed-price contract is to provide 4,566,637,211 units of the YF-VAX 1 dose vaccine to the DLA, with a period of performance through December 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,113.42, is for the delivery of 4,568,091,643 doses of the YF-VAX vaccine with an ultimate completion date of May 14, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,134.20, is for the delivery of 4,568,113 units of the YF-VAX 1 dose vaccine. The contract is a firm fixed-price delivery order with a completion date of May 20, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award is for the delivery of 4567247353 units of the YF-VAX 1 dose vaccine vials, with a ceiling value of $1,113.42 and a completion date of February 28, 2025. The award is a firm fixed-price delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,634.90, is for the supply of 4,565,752,490 doses of the YF-VAX 1 vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which runs through December 31, 2025. The IDC allows...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPQJ2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $27,835.50 and is a delivery order type with a firm fixed-price pricing structure. The contract is for the delivery of 4,568,087,344 units of the YF-VAX 1 dose vaccine and has a completion date of May 16, 2025. This contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide.

Generated 7/25/25, 11:11 AM